QBFM
AGN

QS Batterymarch Financial Management’s Allergan plc AGN Stock Holding History

QS Batterymarch Financial Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-9,165
Closed -$1.89M – 1103
2014
Q1 		$1.89M Sell
9,165
-300
-3% -$59.4K 0.04% 518
2013
Q4 		$1.59M Sell
9,465
-200
-2% -$31.3K 0.03% 536
2013
Q3 		$1.39M Buy
9,665
+860
+10% +$115K 0.03% 562
2013
Q2 		$1.11M Buy
+8,805
New +$997K 0.02% 611

Other funds holding AGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
IIS
Ignis Investment Services Edinburgh, United Kingdom $29.9B AUM

QS Batterymarch Financial Management's AGN Position: Q2 2014 in Review

QS Batterymarch Financial Management sold out of Allergan plc (AGN) in Q2 2014, closing a stake of 9,165 shares — an estimated $1.89M sold.

QS Batterymarch Financial Management first reported a position in AGN in Q2 2013 and held it in 4 quarters. The position peaked at $1.89M in Q1 2014. 674 funds tracked by Wall St. Rank hold AGN as of Q2 2014.

  • QS Batterymarch Financial Management reported no remaining Allergan plc position as of Q2 2014 after selling out during the quarter.
  • QS Batterymarch Financial Management sold 9,165 Allergan plc shares in Q2 2014, an estimated $1.89M.
  • QS Batterymarch Financial Management first reported a position in Allergan plc in Q2 2013 and held it in 4 quarters.
  • QS Batterymarch Financial Management's Allergan plc position peaked at $1.89M in Q1 2014.
  • 674 funds tracked by Wall St. Rank held Allergan plc as of Q2 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q2 2014, filed 14 Aug 2014.